Case studies
Business development services - Slovak private laboratory testing provider
Case: Product strategy, introduction of new products to the portfolio, including the state-of-the-art technologies not previously present in the respective markets,
Testimonial: "Thank you for everything you did for us."
Business development services - The award-winning French CEA spin-off
Case: Lead generation and qualification, established first market traction for the spin-off company and their CAPEX-grade scientific equipment in the Central Europe.
Testimonial: "We are very satisfied with the the results obtained." - Denis, CEO, Eloquant Nanoimaging
"You really are choix pertinent." - Bruno, Scientific Lead/Research Group Leader, Eloquant Nanoimaging
Market access services - Swedish digital health start-up
Case: Provided a framework for the market access strategy in the Austrian market.
Testimonial: "Team at Ambiom works in a structured way, presents their outcomes and proposals with associated substantiated data. During the process, we received continuous updates, our contact person was available and delivered according to schedule." - Filip, Partner, Healo
Business development services - Portuguese biotech spin-off
Case: rNPV asset valuation
Testimonial: "Ambiom accounts with specialized people to provide highly professional and adequate answers to address the client needs. For NeuroSoV the molecule evaluation service provided by Ambiom is a key instrument that we are using to scale in our roadmap. Furthermore, we count with Ambiom on a regular basis as they assist us in every step of our early staged company." - Dina, CEO, NeuroSov
Business development services - Swiss NGO
Case: Pro-bono business development
Testimonial: "We have worked with Ambiom on a pro-bono basis, and have received valuable services in identifying the right geographies, our case and the right partners in these respective geographies. Ambiom has played a key role in the first steps towards our mission of bringing the medicines where they are needed the most." - ShareMedSwiss
